due to an enzymic attack on a specific substrate, probably of a polysaccharide nature, in the cell. They therefore tried the effect of a number of polysaccharides on the reaction. Several of these, particularly apple pectin, inhibited haemagglutinatio n ; furthermore, the apple pectin also inhibited multiplication of the virus in egg embryo.
In conclusion, it should be stressed that a complete understanding of the function of individual essential metabolites in cell metabolism, and of the comparative specificity of requirement by host and micro-organism, is one of the essentials for a profitable exploitation of growth-factor analogues as potential chemotherapeutic agents. And the analogues themselves are proving to be valuable tools in such fundamental investigations whether or not they are themselves useful as thera peutic agents. Functional relations between analogue and growth factor Evidence connecting the action of an analogue with its parent growth factor is of three main types.
I. Antagonism in action
This can be the clearest of all types of evidence; it has been much discussed, classified, and subjected to mathematical expression. For th at reason I will say most about other types of evidence, and make only two observations concerning this first category, (a) The antagonism can be observed at various levels: that of an overall biological effect such as growth, or a t th at of an individual enzymic T a b l e 1. System s in w h ic h a n ta g o n ism b e t w e e n p a n t o t h e n ic acid (I) AND PANTOYLTAURINE (II) HAS BEEN OBSERVED 1. C hem otherapeutic: protection of infected r a t from haem olytic streptococci. 2. Microbiological: streptococcal growth. 3. A series of enzyme reactions: resulting in assim ilation of pantothenate to growing strepto cocci. 4. A simpler enzyme system : resulting in inactivation of pantothenate by non-proliferating streptococci during glycolysis. process in which the growth factor takes part. Such observations can be employed in understanding the effect on growth, in terms of events in simpler systems (table 1; Mcllwain 1947) . (6) There are varying degrees of specificity in the antagonistic relationships between a given inhibitor and growth factors. In the simplest case, only one growth factor may be recognized as antagonist; as is panto thenate to the action of pantoyltaurine on streptococci. In other cases, the types of antagonist can give clues to the action of the antibiotic; as with p-aminobenzoic acid, Lactobacillus casei factor, and the pyrimidines which antagonize sulphonamides. Such multiple antagonists can give clues to the nature of the systems affected by the analogues.
II. Specificity of action
In several instances a correlation is found between the species of organisms which require a given substance for growth, and the species which are susceptible to inhibition by a given antibiotic. An instance is given by Woolley (1945-6) of the use of such data as evidence for functional connexion between thiamine and pyrithiamine (for structure see table 2). Similar correlations have been found in the actions of pantoyltaurine on different microbial species, and their need for pantothenic acid (Mcllwain 1942) . Other analogues have, however, a range of action which includes organisms which do not require preformed the corresponding growth essential. Of this category are sulphanilamide and phenylpantothenone (Woolley 1945) . Findings such as those with pyrithiamine or pantoyltaurine present interesting problems because they suggest that the more exacting organisms possess processes (susceptible to inhibition) additional to those of the less exacting strains. The reasons for the correlation in such cases are not clear, and may not be the same in the different cases. Production of a large excess of growth factor by the less exacting strains has not been found to offer an explanation in the instances quoted above. Organisms requiring a substance as growth factor may differ from those synthesizing the substance, in possessing specific means of assimilating it which are susceptible to inhibition. This would imply evolution to more exacting organisms to be primarily conditioned by gain, and not by loss, of function. Also, the route through which a higher, functioning derivative of the growth factor is synthesized may not involve the free growth factor. A further possibility is of metabolic change in the analogue.
III. Characters of the action of the analogue
Evidence of this category has been adduced mainly in connexion with the actions of analogues on higher animals. Here Woolley's work is outstanding. He has assessed the changes in form and behaviour of experimental animals following administration of the analogues listed in table 2, and observed changes similar to those of the corresponding avitaminoses. There is scope for similar work with many other organisms; insects, plants, and even micro-organisms. This is very much a challenge to microbiologists to learn more about changes which precede total loss of function. Thus, changes in protein make-up may be determined by immunological methods. Changes in the form of bacterial colonies and cells, or of their capsules (such as have been observed to follow nutritional changes), could be used as criteria for comparing the effects of withdrawing a nutrient with that of adding an analogue. The type and rate of bacterial growth can also be followed in much more detail than is commonly observed, and abnormal metabolites may be observed to be produced in the presence of subinhibitory concentrations of antibiotics (Fox 1942; Stettin & Fox 1945) . Such changes may give very direct clues to the action of the analogue; in at least one instance, th at of biotin and biotin sulphone, the growth factor itself was observed to be released by the analogue from its combination with a protein. 
Classification of the actions of analogues
In the majority of recorded instances, therefore, the actions of analogues of growth factors can be seen to be connected in some way with that of the growth factor itself. Now the growth factors of which we are speaking are chemical sub stances ; after growth of organisms, necessarily in their presence, the substances are found in the cells or tissues of the organism concerned, either as such or in combin ation. Very often they can be observed there to be both undergoing and influencing further chemical changes.
These very general observations give the basis for a classification of the action of the analogues: they may effect either (1) assimilation of the growth factor (2) steps in its conversion to a functioning form or (3) its functioning.
(
1), (2) Assimilation and synthesis
In some instances no basis may exist for differentiation between these two stages; in other cases they are known to be distinct. Only rarely have serious attempts been made to differentiate between the two processes in relation to the action of analogues. Assimilation of a growth essential is often a considerable process; nutrient or tissue fluids may contain nicotinic acid, thiamine or riboflavin in con centrations of 10-6 to 10_7m , and tissue cells or micro-organisms contain them or their derivatives at 10 3 or 10~4m . Active and specific processes are necessary to bring about such concentration; for only certain substances are removed from the environment of cells in this way. But the processes causing assimilation may not be distinct from those which cause chemical elaboration of the growth essentials to the forms in which they function. Thus, almost all the nicotinamide of bacterial cells exists as nucleotides. To determine whether there existed, for example, a process for the assimilation of nicotinamide which was distinct from th at forming the (pyridine N)-C link of co-enzymes I or II, would require specific evidence, such as the measurement of free nicotinamide within and without cells in which that process had been inhibited. Such observations do not appear to have been made. It might seem possible to obtain data on assimilation of the co-enzymes themselves by comparable measurements, as they certainly exist as such in cells; but here we find that they are rapidly broken down if added (Mcllwain & Hughes 1948) ; and in no instance in which investigations have been carried out have the co-enzymes proved to constitute an organism's minimal requirements for nicotinamide derivatives. Methionine sulphoxide (cf. Borek, Miller, Scheiness & Waelsch 1946; Waelsch, Owades, Miller & Borek 1946) , which inhibits the growth of streptococci by processes shown by methods of § I above to be related to the formation of gluta mine, has been investigated from this point of view (Mcllwain, Roper & Hughes 1948; Roper & Mcllwain 1948 ; for formulae see table 3). Reactions in which glutamic acid is known to take part in these organisms are shown in figure 1. The formation of glutamine could be prevented either by stopping the entry of glutamic acid to the cells, or by stopping the formation of glutamine from glutamic acid after it had entered. We actually found th at a concentration of sulphoxide which lowered the synthesized glutamine of streptococci from 0-70 to 0-35 /./mol./g. lowered the entry of glutamic acid only from 30 to 25//mol./g. The sulphoxide therefore appeared to act after assimilation of glutamic acid.
Though differentiation between the action of analogues on assimilation and synthesis may only rarely have been realized, action on either of the two processes results in a lesser quantity of functioning growth factor in the cells concerned, and this can be readily differentiated from the third category in which action of an analogue is on the functioning of a growth factor. Sulphanilamide and pantoyltaurine do not appear to influence the functioning of the corresponding growth factors when once these are already in action in the cell. Several characteristics of the effects of the compounds on microbial growth can be seen to result from this specificity in their point of action; the latent period before their effect on growth is manifest; their bacteriostatic, not bactericidal action, and the absence of actual displacement of the growth factor from the cells, by the analogue (Mcllwain 1945) .
(3) Functioning
Growth essentials subserve many types of function in cells. Glucose, oxygen, or some amino-acids are found to be taking part in major reactions as sources of material and energy; nicotinamide, aneurin, or pantothenic acid as parts of systems by which changes of the first category are brought about.
Analogues of oxygen are, of course, among the most potent of antibiotics. Carbon monoxide and cyanides can cause death in a few seconds when present in concen trations only a fraction of that of the oxygen with which they compete. They exhibit a specificity of action which in the case of cyanides is applied commercially on a large scale, and their success should be a challenge and a stimulus to those attempting to produce analogues of biological interest.
There are a few instances in which analogues of substances subserving the latter catalytic type of function have been demonstrated to act at the point of catalysis. It has been reported th at pyridine-3-sulphonic acid inhibited glucose oxidation, in which the nicotinamide nucleotides functioned (Euler 1942), but no attempts were made to correlate this effect with the antibiotic action of the substance. Such evidence is, however, available in the case of the actions of glutamine and the corresponding hydrazide on streptococcal growth. The action of the hydrazide was shown by methods of § § I and II to be related to glutamine, but its action proved to be distinct from th at of the sulphoxide derived from methionine (figure 1); it did not affect the assimilation of glutamic acid or the synthesis of glutamine, but it inhibited the breakdown of glutamine to glutamic acid and NH3, a process which was associated with increase in glycolysis. The inhibition of growth was correlated with the inhibition of breakdown of glutamine. There is also evidence suggesting th at glucoascorbic acid inhibits the oxidation of tyrosine by ascorbic acid (cf. Woolley 1946).
It will be seen from this survey that serious study of the point of action of growth-factor analogues has been barely begun. It is, however, very necessary that the subject should be pursued if correlations are attempted between the biological effects of analogues, and their chemical structures. The actions of the sulphoxide derived from methionine and of glutamyl hydrazine, though both antagonized by glutamine, are biochemically distinct. Localization of the point of action of an analogue, as illustrated in figure 1, is thus an essential preliminary to any inter pretation of their potencies in electromeric terms.
Se l e c t iv e t o x ic it y , an e s s e n t ia l r e q u ir e m e n t fo r
SUCCESSFUL CHEMOTHERAPY

B y T. S. W o r k
Chemotherapeutic research is judged, ultimately, by its ability to produce new and successful drugs for the treatm ent of disease. Success may be fortuitous or it may be the result of an inspired guess into the future. I t is my task to-day to examine current theories on metabolite analogues and to assess their value as a pointer towards further progress.
A glance at past progress may help us to assess more fairly the present position. Table 4 gives a short list of notable chemotherapeutic drugs together with their origin and date of introduction into European medicine.
